Format
Sort by
Items per page

Send to

Choose Destination

Best matches for ESTRADIOL/TU:

Search results

Items: 1 to 20 of 11086

1.

A Single-centre, Retrospective, Observational Analysis of Fulvestrant for Recurrent/metastatic Breast Cancer According to Metastatic Site.

Ozawa H, Sata A, Fukui R, Bun A, Higuchi T, Fujimoto Y, Miyagawa Y, Imamura M, Miyoshi Y.

Anticancer Res. 2019 Oct;39(10):5653-5662. doi: 10.21873/anticanres.13762.

PMID:
31570463
2.

A combined, bioidentical, oral, 17β-estradiol and progesterone capsule for the treatment of moderate to severe vasomotor symptoms due to menopause.

Archer DF, Bernick BA, Mirkin S.

Expert Rev Clin Pharmacol. 2019 Aug;12(8):729-739. doi: 10.1080/17512433.2019.1637731. Epub 2019 Jul 22. Review.

PMID:
31282768
3.

Alpelisib: First Global Approval.

Markham A.

Drugs. 2019 Jul;79(11):1249-1253. doi: 10.1007/s40265-019-01161-6. Review.

PMID:
31256368
4.

Discovery of chalcone-modified estradiol analogs as antitumour agents that Inhibit tumour angiogenesis and epithelial to mesenchymal transition.

Wang C, Li L, Fu D, Qin T, Ran Y, Xu F, Du X, Gao H, Sun S, Yang T, Zhang X, Huo J, Zhao W, Zhang Z, Shi X.

Eur J Med Chem. 2019 Aug 15;176:135-148. doi: 10.1016/j.ejmech.2019.04.071. Epub 2019 Apr 30.

PMID:
31102934
5.

Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer.

André F, Ciruelos E, Rubovszky G, Campone M, Loibl S, Rugo HS, Iwata H, Conte P, Mayer IA, Kaufman B, Yamashita T, Lu YS, Inoue K, Takahashi M, Pápai Z, Longin AS, Mills D, Wilke C, Hirawat S, Juric D; SOLAR-1 Study Group.

N Engl J Med. 2019 May 16;380(20):1929-1940. doi: 10.1056/NEJMoa1813904.

PMID:
31091374
6.

Fulvestrant-induced toxic epidermal necrolysis.

Morales-Conde M, López-Ibáñez N, Calvete-Candenas J, Mendonça FMI.

An Bras Dermatol. 2019 Mar-Apr;94(2):218-220. doi: 10.1590/abd1806-4841.20197964. Epub 2019 May 9.

7.

Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study.

Yi Z, Ma F, Liu B, Guan X, Li L, Li C, Qian H, Xu B.

BMC Cancer. 2019 May 14;19(1):442. doi: 10.1186/s12885-019-5668-3.

8.

Sex dichotomy in the course of experimental latent toxoplasmosis.

Hegazy MM, Elmehankar MS, Azab MS, El-Tantawy NL, Abdel-Aziz A.

Exp Parasitol. 2019 Jul;202:15-21. doi: 10.1016/j.exppara.2019.05.003. Epub 2019 May 9.

PMID:
31078550
9.

Effect of the duration of estradiol priming prior to progesterone administration on endometrial gene expression in anestrous mares.

Silva ESM, Cuervo-Arango J, de Ruijter-Villani M, Klose K, Oquendo PS, Stout TAE.

Theriogenology. 2019 Jun;131:96-105. doi: 10.1016/j.theriogenology.2019.03.025. Epub 2019 Mar 28.

PMID:
30959441
10.

Vascular and morphological features of the corpus luteum 12 to 20 days after timed artificial insemination in dairy cattle.

Siqueira LG, Arashiro EK, Ghetti AM, Souza ED, Feres LF, Pfeifer LF, Fonseca JF, Viana JH.

J Dairy Sci. 2019 Jun;102(6):5612-5622. doi: 10.3168/jds.2018-15853. Epub 2019 Apr 4.

PMID:
30954257
11.

Comparison between the 5-day cosynch and 7-day estradiol-based protocols for synchronization of ovulation and timed artificial insemination in suckled BOS taurus BEEF cows.

Bilbao MG, Zapata LO, Romero Harry H, Perez Wallace S, Farcey MF, Gelid L, Palomares RA, Ferrer MS, Bartolome JA.

Theriogenology. 2019 Jun;131:72-78. doi: 10.1016/j.theriogenology.2019.01.027. Epub 2019 Jan 31.

PMID:
30947077
12.

Endometrial preparation for third-party parenting and cryopreserved embryo transfer.

Smith MB, Paulson RJ.

Fertil Steril. 2019 Apr;111(4):641-649. doi: 10.1016/j.fertnstert.2019.02.010. Review.

PMID:
30929721
13.

Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer.

Mehta RS, Barlow WE, Albain KS, Vandenberg TA, Dakhil SR, Tirumali NR, Lew DL, Hayes DF, Gralow JR, Linden HH, Livingston RB, Hortobagyi GN.

N Engl J Med. 2019 Mar 28;380(13):1226-1234. doi: 10.1056/NEJMoa1811714. Erratum in: N Engl J Med. 2019 Jun 6;380(23):2282.

PMID:
30917258
14.

Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer.

Formisano L, Lu Y, Servetto A, Hanker AB, Jansen VM, Bauer JA, Sudhan DR, Guerrero-Zotano AL, Croessmann S, Guo Y, Ericsson PG, Lee KM, Nixon MJ, Schwarz LJ, Sanders ME, Dugger TC, Cruz MR, Behdad A, Cristofanilli M, Bardia A, O'Shaughnessy J, Nagy RJ, Lanman RB, Solovieff N, He W, Miller M, Su F, Shyr Y, Mayer IA, Balko JM, Arteaga CL.

Nat Commun. 2019 Mar 26;10(1):1373. doi: 10.1038/s41467-019-09068-2.

15.

Pharmacotherapy for the treatment of vaginal atrophy.

Donders GGG, Ruban K, Bellen G, Grinceviciene S.

Expert Opin Pharmacother. 2019 May;20(7):821-835. doi: 10.1080/14656566.2019.1574752. Epub 2019 Mar 21. Review.

PMID:
30897020
16.

Histoarchitecture restoration of cerebellar sub-layers as a response to estradiol treatment following Kainic acid-induced spinal cord injury.

Farag A, Lashen S, Eltaysh R.

Cell Tissue Res. 2019 Jun;376(3):309-323. doi: 10.1007/s00441-019-02992-1. Epub 2019 Feb 20.

PMID:
30788578
17.

Jiedu Huoxue decoction improves inflammation in rat type III prostatitis: The importance of the NF-κB signalling pathway.

Yan Z, Huang C, Huang G, Wu Y, Wang J, Yi J, Mao W, Wang W.

Andrologia. 2019 Jun;51(5):e13245. doi: 10.1111/and.13245. Epub 2019 Feb 6.

PMID:
30729553
18.

Effect of High-dose Vitamin C Combined With Anti-cancer Treatment on Breast Cancer Cells.

Lee SJ, Jeong JH, Lee IH, Lee J, Jung JH, Park HY, Lee DH, Chae YS.

Anticancer Res. 2019 Feb;39(2):751-758. doi: 10.21873/anticanres.13172.

PMID:
30711954
19.

Bioidentical hormone therapy in menopause: relevance in dermatology.

Borda LJ, Wong LL, Tosti A.

Dermatol Online J. 2019 Jan 15;25(1). pii: 13030/qt4c20m28z. Review.

20.

Supplemental Content

Loading ...
Support Center